Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study.
Kalicińska E, Szymczak D, Andrasiak I, Bogucka-Fedorczuk A, Zińczuk A, Szymański W, Biernat M, Rymko M, Semeńczuk G, Jabłonowska P, Rybka J, Simon K, Wróbel T. Kalicińska E, et al. Transl Oncol. 2021 Jan;14(1):100943. doi: 10.1016/j.tranon.2020.100943. Epub 2020 Nov 11. Transl Oncol. 2021. PMID: 33204385 Free PMC article.
The comparison of effectiveness and safety between different biosimilars of G-CSF in the mobilization of peripheral blood stem cells (PBSCs) for autologous transplantation (autologous peripheral blood stem cell transplantation, auto-PBSCT).
Wicherska-Pawłowska K, Rybka J, Prajs I, Szmigiel K, Tyc J, Frączak E, Biedroń M, Kalicińska E, Szymczak D, Wróbel T. Wicherska-Pawłowska K, et al. Among authors: kalicinska e. J Clin Apher. 2020 Jan;35(1):4-8. doi: 10.1002/jca.21750. Epub 2019 Oct 30. J Clin Apher. 2020. PMID: 31663634
Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma.
Bogucka-Fedorczuk A, Czyz A, Kalicińska E, Sawicki M, Laszkowska-Lewko M, Wicherska-Pawłowska K, Rybka J, Szeremet A, Prajs I, Szymczak D, Wróbel T. Bogucka-Fedorczuk A, et al. Among authors: kalicinska e. J Clin Apher. 2020 Aug;35(4):246-254. doi: 10.1002/jca.21784. Epub 2020 Apr 16. J Clin Apher. 2020. PMID: 32298020
Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
Kalicińska E, Szymczak D, Zińczuk A, Adamik B, Smiechowicz J, Skalec T, Nowicka-Suszko D, Biernat M, Bogucka-Fedorczuk A, Rybka J, Martuszewski A, Gozdzik W, Simon K, Wróbel T. Kalicińska E, et al. Cells. 2021 May 23;10(6):1293. doi: 10.3390/cells10061293. Cells. 2021. PMID: 34071149 Free PMC article.
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study.
Kalicińska E, Biernat M, Rybka J, Zińczuk A, Janocha-Litwin J, Rosiek-Biegus M, Morawska M, Waszczuk-Gajda A, Drozd-Sokołowska J, Szukalski Ł, Rymko M, Jabłonowska P, Simon K, Wróbel T. Kalicińska E, et al. J Clin Med. 2021 Sep 24;10(19):4373. doi: 10.3390/jcm10194373. J Clin Med. 2021. PMID: 34640390 Free PMC article.
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.
Zaleska J, Kwasnik P, Paziewska M, Purkot J, Szabelak A, Jurek M, Masny N, Dziatkiewicz I, Pronobis-Szczylik B, Piebiak A, Szymczyk A, Jarosz-Chudzik K, Bolkun L, Kozlowska K, Piszcz J, Subocz E, Halka J, Bator M, Kalicinska E, Wrobel T, Usnarska-Zubkiewicz L, Rybka J, Deren-Wagemann I, Szyca-Smieszniak M, Dybko J, Hus I, Pula B, Cichocka E, Rymko M, Zdunczyk D, Ziarkiewicz M, Basak GW, Bullinger L, Giannopoulos K. Zaleska J, et al. Among authors: kalicinska e. Int J Cancer. 2023 Feb 15;152(4):705-712. doi: 10.1002/ijc.34209. Epub 2022 Jul 27. Int J Cancer. 2023. PMID: 35830214 Free PMC article.
25 results